Click for best price
Postpemic Era Colorectal Cancer Therapeutics Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
(Post-pandemic Era)-Global Colorectal Cancer Therapeutics Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Colorectal Cancer Therapeutics industry at home and abroad, estimate the overall market scale of the Colorectal Cancer Therapeutics industry and the market share of major countries, Colorectal Cancer Therapeutics industry, and study and judge the downstream market demand of Colorectal Cancer Therapeutics through systematic research, Analyze the competition pattern of Colorectal Cancer Therapeutics, so as to help solve the pain points of various stakeholders in Colorectal Cancer Therapeutics industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Colorectal Cancer Therapeutics Market by Research Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Colorectal Cancer Therapeutics Market?
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
Major Type of Colorectal Cancer Therapeutics Covered in Research report:
Diagnostics
Therapeutics
Application Segments Covered in Research Market
Hospitals
Clinic
Research Institutions
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Colorectal Cancer Therapeutics Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
98 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Colorectal Cancer Therapeutics Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Colorectal Cancer Therapeutics Market by Value
2.2.1 Global Colorectal Cancer Therapeutics Revenue by Type
2.2.2 Global Colorectal Cancer Therapeutics Market by Value
2.3 Global Colorectal Cancer Therapeutics Market by Sales
2.3.1 Global Colorectal Cancer Therapeutics Sales by Type
2.3.2 Global Colorectal Cancer Therapeutics Market by Sales
3. The Major Driver of Colorectal Cancer Therapeutics Industry
3.1 Historical & Forecast Global Colorectal Cancer Therapeutics Sales and Revenue (2018-2028)
3.2 Largest Application for Colorectal Cancer Therapeutics (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Colorectal Cancer Therapeutics Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Colorectal Cancer Therapeutics Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Colorectal Cancer Therapeutics Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Colorectal Cancer Therapeutics Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Colorectal Cancer Therapeutics Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Colorectal Cancer Therapeutics Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Colorectal Cancer Therapeutics Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Colorectal Cancer Therapeutics Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Colorectal Cancer Therapeutics Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Colorectal Cancer Therapeutics Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Colorectal Cancer Therapeutics Average Price Trend
13.1 Market Price for Each Type of Colorectal Cancer Therapeutics in US (2018-2022)
13.2 Market Price for Each Type of Colorectal Cancer Therapeutics in Europe (2018-2022)
13.3 Market Price for Each Type of Colorectal Cancer Therapeutics in China (2018-2022)
13.4 Market Price for Each Type of Colorectal Cancer Therapeutics in Japan (2018-2022)
13.5 Market Price for Each Type of Colorectal Cancer Therapeutics in India (2018-2022)
13.6 Market Price for Each Type of Colorectal Cancer Therapeutics in Korea (2018-2022)
13.7 Market Price for Each Type of Colorectal Cancer Therapeutics in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Colorectal Cancer Therapeutics in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Colorectal Cancer Therapeutics Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Colorectal Cancer Therapeutics
15. Colorectal Cancer Therapeutics Competitive Landscape
15.1 Taiho Pharma
15.1.1 Taiho Pharma Company Profiles
15.1.2 Taiho Pharma Product Introduction
15.1.3 Taiho Pharma Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Merck KGaA
15.2.1 Merck KGaA Company Profiles
15.2.2 Merck KGaA Product Introduction
15.2.3 Merck KGaA Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Amgen
15.3.1 Amgen Company Profiles
15.3.2 Amgen Product Introduction
15.3.3 Amgen Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Takeda
15.4.1 Takeda Company Profiles
15.4.2 Takeda Product Introduction
15.4.3 Takeda Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 Roche
15.5.1 Roche Company Profiles
15.5.2 Roche Product Introduction
15.5.3 Roche Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Eli Lilly
15.6.1 Eli Lilly Company Profiles
15.6.2 Eli Lilly Product Introduction
15.6.3 Eli Lilly Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Sanofi
15.7.1 Sanofi Company Profiles
15.7.2 Sanofi Product Introduction
15.7.3 Sanofi Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Regeneron
15.8.1 Regeneron Company Profiles
15.8.2 Regeneron Product Introduction
15.8.3 Regeneron Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Bayer
15.9.1 Bayer Company Profiles
15.9.2 Bayer Product Introduction
15.9.3 Bayer Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Onyx
15.10.1 Onyx Company Profiles
15.10.2 Onyx Product Introduction
15.10.3 Onyx Colorectal Cancer Therapeutics Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Bristol-Myers Squib
15.12 Sumitomo Dainippon Pharma
15.13 Array BioPharma
15.14 Hutchison MediPharma
15.15 Jiangsu Hengrui Medicine
15.16 Jiangsu Chia-Tai Tianqing
15.17 Suzhou Zelgen Biopharmaceuticals
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Colorectal Cancer Therapeutics Industry (Volume)
Figure 2. Colorectal Cancer Therapeutics Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2022
Figure 5. US Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Colorectal Cancer Therapeutics Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Colorectal Cancer Therapeutics Revenue, by Type (Million USD) (2018-2028)
Table 4. Colorectal Cancer Therapeutics Sales, by Type (K Unit) (2018-2028)
Table 5. Colorectal Cancer Therapeutics Sales (K Unit) by Application (2018-2028)
Table 6. Colorectal Cancer Therapeutics Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Colorectal Cancer Therapeutics Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Colorectal Cancer Therapeutics Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Colorectal Cancer Therapeutics in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Taiho Pharma Profiles
Table 61. Taiho Pharma Colorectal Cancer Therapeutics Product Introduction
Table 62. Taiho Pharma Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Taiho Pharma Strategic initiatives
Table 64. Merck KGaA Profiles
Table 65. Merck KGaA Colorectal Cancer Therapeutics Product Introduction
Table 66. Merck KGaA Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Merck KGaA Strategic initiatives
Table 68. Amgen Profiles
Table 69. Amgen Colorectal Cancer Therapeutics Product Introduction
Table 70. Amgen Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Amgen Strategic initiatives
Table 72. Takeda Profiles
Table 73. Takeda Colorectal Cancer Therapeutics Product Introduction
Table 74. Takeda Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Takeda Strategic initiatives
Table 76. Roche Profiles
Table 77. Roche Colorectal Cancer Therapeutics Product Introduction
Table 78. Roche Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Roche Strategic initiatives
Table 80. Eli Lilly Profiles
Table 81. Eli Lilly Colorectal Cancer Therapeutics Product Introduction
Table 82. Eli Lilly Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Eli Lilly Strategic initiatives
Table 84. Sanofi Profiles
Table 85. Sanofi Colorectal Cancer Therapeutics Product Introduction
Table 86. Sanofi Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Sanofi Strategic initiatives
Table 88. Regeneron Profiles
Table 89. Regeneron Colorectal Cancer Therapeutics Product Introduction
Table 90. Regeneron Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Regeneron Strategic initiatives
Table 92. Bayer Profiles
Table 93. Bayer Colorectal Cancer Therapeutics Product Introduction
Table 94. Bayer Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Bayer Strategic initiatives
Table 97. Onyx Profiles
Table 98. Onyx Colorectal Cancer Therapeutics Product Introduction
Table 99. Onyx Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Onyx Strategic initiatives
Table 101. Bristol-Myers Squib Profiles
Table 102. Bristol-Myers Squib Colorectal Cancer Therapeutics Product Introduction
Table 103. Bristol-Myers Squib Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Bristol-Myers Squib Strategic initiatives
Table 105. Sumitomo Dainippon Pharma Profiles
Table 106. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Product Introduction
Table 107. Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Sumitomo Dainippon Pharma Strategic initiatives
Table 109. Array BioPharma Profiles
Table 110. Array BioPharma Colorectal Cancer Therapeutics Product Introduction
Table 111. Array BioPharma Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Array BioPharma Strategic initiatives
Table 113. Hutchison MediPharma Profiles
Table 114. Hutchison MediPharma Colorectal Cancer Therapeutics Product Introduction
Table 115. Hutchison MediPharma Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Hutchison MediPharma Strategic initiatives
Table 117. Jiangsu Hengrui Medicine Profiles
Table 118. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Product Introduction
Table 119. Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. Jiangsu Hengrui Medicine Strategic initiatives
Table 121. Jiangsu Chia-Tai Tianqing Profiles
Table 122. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Product Introduction
Table 123. Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Jiangsu Chia-Tai Tianqing Strategic initiatives
Table 125. Suzhou Zelgen Biopharmaceuticals Profiles
Table 126. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Product Introduction
Table 127. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Sales (Unit), Revenue (Million USD) (2018-2022)
Table 128. Suzhou Zelgen Biopharmaceuticals Strategic initiatives
